An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial ...
An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial design, one of the most difficult steps in drug development, according to a ...
FDA’s PDUFA goal date is November 1, 2026; If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell disease; CAMBRIDGE, Mass., Ju ...
In this pooled analysis of randomized crossover trials, chronic mild sleep restriction was associated with modest increases ...
Phase 2b Elumina trial; topline data anticipated in Q4 2026 (ClinicalTrials.gov: NCT06524830) AtaiBeckley plans to advance VLS-01 into major depressive disorder (MDD) in Phase 3, with generalized ...
A new randomized clinical trial from investigators at Mass General Brigham's Neuroscience Institute and Department of Psychiatry suggests that using personalized brain imaging to guide transcranial ...
3 Integrative Sports Science Research Laboratory, Yonsei University, Seoul, Korea, South 4 Frontier Research Institute of Convergence Sports Science, Yonsei University, Seoul, Korea, South 5 Yonsei ...
A randomized field experiment found AI Overviews reduced organic clicks 38% on queries where they appeared. Zero-click searches rose from 54% to 72% when AI Overviews were shown. Removing AI Overviews ...
Tristan Jurkovich began his career as a journalist in 2011. His childhood love of video games and writing fuel his passion for archiving this great medium’s history. He dabbles in every genre, but ...
Nevada City Calif. – The Nevada County Elections Office invites members of the public to observe a randomized alphabet drawing to determine the order of some candidate names on the ballot for the June ...
Abstract: In this paper, we study the sample complexity of probabilistic methods for control of uncertain systems. In particular, we show the role of the binomial distribution for some problems ...
Marketed as a fertility booster, the antioxidant Impryl showed no benefit in a large Dutch trial, and even reduced pregnancy rates at the critical treatment window, challenging supplement claims.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results